277 related articles for article (PubMed ID: 19074461)
1. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.
Pacheco CD; Elrick MJ; Lieberman AP
Hum Mol Genet; 2009 Mar; 18(5):956-65. PubMed ID: 19074461
[TBL] [Abstract][Full Text] [Related]
2. Tau normal function influences Niemann-Pick type C disease pathogenesis in mice and modulates autophagy in NPC1-deficient cells.
Pacheco CD; Elrick MJ; Lieberman AP
Autophagy; 2009 May; 5(4):548-50. PubMed ID: 19332999
[TBL] [Abstract][Full Text] [Related]
3. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
Tamura A; Yui N
J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
[TBL] [Abstract][Full Text] [Related]
4. Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.
Elrick MJ; Yu T; Chung C; Lieberman AP
Hum Mol Genet; 2012 Nov; 21(22):4876-87. PubMed ID: 22872701
[TBL] [Abstract][Full Text] [Related]
5. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
Chung C; Puthanveetil P; Ory DS; Lieberman AP
Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
[TBL] [Abstract][Full Text] [Related]
7. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
8. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.
Lloyd-Evans E; Morgan AJ; He X; Smith DA; Elliot-Smith E; Sillence DJ; Churchill GC; Schuchman EH; Galione A; Platt FM
Nat Med; 2008 Nov; 14(11):1247-55. PubMed ID: 18953351
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β metabolism in Niemann-Pick C disease models and patients.
Mattsson N; Olsson M; Gustavsson MK; Kosicek M; Malnar M; Månsson JE; Blomqvist M; Gobom J; Andreasson U; Brinkmalm G; Vite C; Hecimovic S; Hastings C; Blennow K; Zetterberg H; Portelius E
Metab Brain Dis; 2012 Dec; 27(4):573-85. PubMed ID: 22935999
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
11. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability.
Meske V; Erz J; Priesnitz T; Ohm TG
Neurobiol Dis; 2014 Apr; 64():88-97. PubMed ID: 24412309
[TBL] [Abstract][Full Text] [Related]
12. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
14. Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling.
Reddy JV; Ganley IG; Pfeffer SR
PLoS One; 2006 Dec; 1(1):e19. PubMed ID: 17183645
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation.
Smith AF; Vanderah TW; Erickson RP
J Appl Genet; 2020 Dec; 61(4):567-570. PubMed ID: 32794098
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects.
Pacheco CD; Kunkel R; Lieberman AP
Hum Mol Genet; 2007 Jun; 16(12):1495-503. PubMed ID: 17468177
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
[TBL] [Abstract][Full Text] [Related]
18. Primary cilium alterations and expression changes of Patched1 proteins in niemann-pick type C disease.
Formichi P; Battisti C; De Santi MM; Guazzo R; Tripodi SA; Radi E; Rossi B; Tarquini E; Federico A
J Cell Physiol; 2018 Jan; 233(1):663-672. PubMed ID: 28332184
[TBL] [Abstract][Full Text] [Related]
19. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
20. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.
Yu T; Chung C; Shen D; Xu H; Lieberman AP
Hum Mol Genet; 2012 Jul; 21(14):3205-14. PubMed ID: 22505584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
